Evidence map›Paper›PMID 39692505›Full record

ArticleAntimicrobial agents and chemotherapy2025

Performance of a broth microdilution assay for routine minimum inhibitory concentration determination of 14 anti-tuberculous drugs against the

Mikael Mansjö, Carmen Espinosa-Gongora, Ishak Samanci, Ramona Groenheit, Jim Werngren

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. MmpS5-MmpL5 Transporters DeliverCurrent protein & peptide science · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Antimicrobial agents and chemotherapy · 2025
    Article
  8. Article
  9. Identifying Antimicrobial Agents fromBiotech (Basel (Switzerland)) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mikael Mansjö *Public Health Agency of Sweden, Solna, Sweden.ORCID 0000-0001-9289-351X
Carmen Espinosa-Gongora *Public Health Agency of Sweden, Solna, Sweden.ORCID 0000-0002-9536-0548
Ishak SamanciPublic Health Agency of Sweden, Solna, Sweden.
Ramona GroenheitPublic Health Agency of Sweden, Solna, Sweden.ORCID 0000-0003-2696-437X
Jim WerngrenPublic Health Agency of Sweden, Solna, Sweden.ORCID 0000-0003-2500-9792

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This comparative study aimed at qualifying a broth microdilution (BMD) assay for phenotypic drug susceptibility testing (pDST) of

Indexed as

Antitubercular AgentsMycobacterium tuberculosisAmikacinClofazimineCycloserineDiarylquinolinesDrug Resistance, Multiple, BacterialEthambutolEthionamideHumansIsoniazidLevofloxacinLinezolidMicrobial Sensitivity TestsMoxifloxacinNitroimidazolesAmikacinAntitubercular AgentsbedaquilineClofazimineCycloserineDiarylquinolinesEthambutolEthionamideIsoniazidLevofloxacinLinezolidMoxifloxacinNitroimidazolesOPC-67683OxazolespretomanidRifampinantimicrobial susceptibilitybroth microdilutionMIC determinationtuberculosis

Identifiers

PMID39692505
PMCPMC11823602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.